Sector
Health
Historical revenue, net income, net margin and earnings per share of Merck & Co., Inc., year by year from 2010 to 2025. Market data, amounts in US dollars.
Revenue, net income, net margin, earnings per share (EPS) and revenue growth. Amounts in USD.
| Year | Revenue | Net income | Net margin | BPA | Revenue growth |
|---|---|---|---|---|---|
| 2010 | 45,99 billion $ | 861,00 M$ | 1,9 % | 0,28 $ | n/d |
| 2011 | 48,05 billion $ | 6,27 billion $ | 13,1 % | 2,06 $ | +4,5 % |
| 2012 | 47,27 billion $ | 6,17 billion $ | 13,1 % | 2,20 $ | -1,6 % |
| 2013 | 44,03 billion $ | 4,40 billion $ | 10,0 % | 1,50 $ | -6,8 % |
| 2014 | 42,24 billion $ | 11,92 billion $ | 28,2 % | 4,20 $ | -4,1 % |
| 2015 | 39,50 billion $ | 4,44 billion $ | 11,2 % | 1,60 $ | -6,5 % |
| 2016 | 39,81 billion $ | 3,92 billion $ | 9,8 % | 2,07 $ | +0,8 % |
| 2017 | 40,12 billion $ | 2,39 billion $ | 6,0 % | 0,95 $ | +0,8 % |
| 2018 | 42,29 billion $ | 6,22 billion $ | 14,7 % | 2,40 $ | +5,4 % |
| 2019 | 39,12 billion $ | 9,84 billion $ | 25,2 % | 3,84 $ | -7,5 % |
| 2020 | 41,52 billion $ | 7,07 billion $ | 17,0 % | 2,79 $ | +6,1 % |
| 2021 | 48,70 billion $ | 13,05 billion $ | 26,8 % | 5,16 $ | +17,3 % |
| 2022 | 59,28 billion $ | 14,52 billion $ | 24,5 % | 5,73 $ | +21,7 % |
| 2023 | 60,12 billion $ | 365,00 M$ | 0,6 % | 0,14 $ | +1,4 % |
| 2024 | 64,17 billion $ | 17,12 billion $ | 26,7 % | 6,76 $ | +6,7 % |
| 2025 | 64,93 billion $ | 18,25 billion $ | 28,1 % | 7,30 $ | +1,2 % |
Graphical representation of annual amounts (in USD).
Valuation and profitability; price ratios calculated based on the price of 13/11/2026.